PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
12.78%
Net income growth under 50% of ORCL's 98.57%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
3.46%
Less D&A growth vs. ORCL's 22.78%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-100.41%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
0.21%
Less SBC growth vs. ORCL's 3.28%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
850.02%
Well above ORCL's 90.55% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-312.84%
AR is negative yoy while ORCL is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3376.90%
Growth well above ORCL's 285.05%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-6730.77%
Both negative yoy, with ORCL at -98.23%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-24.20%
Negative yoy CFO while ORCL is 40.99%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-85.78%
Both yoy lines negative, with ORCL at -13.11%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
271.33%
Acquisition spending well above ORCL's 99.25%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
62.79%
Purchases well above ORCL's 8.76%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-60.52%
We reduce yoy sales while ORCL is 35.15%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
30.23%
Lower net investing outflow yoy vs. ORCL's 92.34%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
24.56%
We repay more while ORCL is negative at -9.72%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
-436.97%
Negative yoy issuance while ORCL is 17.75%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-89.77%
Both yoy lines negative, with ORCL at -4.96%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.